Merck KGaA and Illumina said today they are partnering with Genea to improve fertility-related technologies and processes within assisted reproductive treatment (ART) labs. The partnership, called the Global Fertility Alliance, is designed to improve ART consistency worldwide and addresses the need for more standardization of fertility processes within ART labs. The companies will formally launch […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has agreed to acquire 100% ownership of Cliniqa Corporation. Cliniqa specializes in the manufacturing and commercialization of quality controls and calibrators as well as bulk reagents used in the clinical diagnostic market. Its controls and reagents are used in a wide variety of diagnostic tests […]
Brisbane, CA, USA and Cambridge, UK — CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value, diagnostic surveillance solutions for transplant recipients and Horizon Discovery Group plc (Horizon), an international life science company supplyingreagent tools and services that power genomics research and the development of […]
Brazil — Illumina, Inc. (NASDAQ:ILMN) today announced it has named Pensabio, a life science, analytical instruments and diagnostics distributor, headquartered in Sao Paolo, Brazil, as its new distribution partner to deliver Illumina sequencing platforms, products and solutions in Brazil. “Pensabio was selected to distribute Illumina products because of its strong presence and reputation as an […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications and The University of Texas MD Anderson Cancer Center have entered into a 2-year Sponsored Research Agreement to support development of multiple next-generation sequencing (NGS)-based gene expression assays for lung cancer subtyping, fusion status and immune profiling. […]
KUALA LUMPUR, Malaysia — QIAGEN announced the opening of its new principal office in Malaysia to serve its growing base of customers for Sample to Insight solutions, enabling them to help fight diseases using molecular diagnostics, break new ground in research for the life sciences and pharmaceutical industry, and protect the public through food safety […]
OMAHA, Neb.– Transgenomic, Inc. (NASDAQ: TBIO) today announced the launch of its new Multiplexed ICE COLD-PCRTM (MX-ICP) CLIA service for mutation detection in cancer patients to enable more informed diagnoses, better treatment decisions and ongoing patient monitoring. The service leverages the ultra-high sensitivity of Transgenomic’s proprietary MX-ICP technology to deliver highly accurate results from almost […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has received the CE Mark for new molecular assays for the detection of Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2), to be run on its molecular platform, illumigene®. The HSV 1&2 assays are additions to the portfolio of molecular tests available […]
KUALA LUMPUR, Malaysia -— QIAGEN today announced the opening of its new principal office in Malaysia to serve its growing base of customers for Sample to Insight solutions, enabling them to help fight diseases using molecular diagnostics, break new ground in research for the life sciences and pharmaceutical industry, and protect the public through food […]
BEND, Ore. — Amplion, developer of BiomarkerBase™, the industry’s leading platform for researching biomarkers in clinical use and development, announces today that BiomarkerBase™ is now the first and only database that includes biomarkers in Laboratory-Developed Tests (LDTs). “Being able to analyze biomarkers used in LDTs, alongside biomarkers in FDA-approved tests, drug labels, and clinical trials, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
